Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-30 · accession 0001628280-23-036053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-01 | 2023-10-30 | BLFS | Rice Michael | Former CEO, Dir | S - Sale | $9.13 | -72.6K | 347.1K | -17% | -$662.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-30 | S | D | 72,603 | $9.13 | 347,085 | D | — | — |